(PHYL) PGIM Active High Yield Bond - Overview
Etf: High Yield Bonds, Below Investment Grade
Dividends
| Dividend Yield | 7.69% |
| Yield on Cost 5y | 8.79% |
| Yield CAGR 5y | 0.17% |
| Payout Consistency | 93.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 2.52% |
| Relative Tail Risk | -0.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.00 |
| Alpha | 2.31 |
| Character TTM | |
|---|---|
| Beta | 0.175 |
| Beta Downside | 0.207 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.52% |
| CAGR/Max DD | 2.07 |
Description: PHYL PGIM Active High Yield Bond December 30, 2025
PHYL (PGIM Active High Yield Bond ETF) allocates at least 80% of its investable assets to a diversified pool of below-investment-grade (high-yield) bonds and comparable derivative positions, including securities that may be in bankruptcy or default at acquisition, provided the Sub-Adviser judges them to meet a minimum credit quality threshold.
Key metrics to watch: the fund’s weighted-average coupon hovers around 7.5% (as of the latest quarterly report), its effective duration is approximately 4.2 years, and the historical default rate for its underlying sector mix is near 2.3% annually. Economic drivers such as the Federal Reserve’s policy stance on interest rates and the health of the U.S. corporate earnings cycle heavily influence spread compression or widening in this segment. Sector exposure is tilted toward energy and industrials, which together account for roughly 30% of the portfolio, making commodity price trends a material performance factor.
For a deeper, data-driven look at PHYL’s risk-adjusted returns and how they compare to peer ETFs, you might explore the analytics platform ValueRay.
What is the price of PHYL shares?
Over the past week, the price has changed by +0.16%, over one month by +0.44%, over three months by +2.30% and over the past year by +8.54%.
Is PHYL a buy, sell or hold?
What are the forecasts/targets for the PHYL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.5 | 13.9% |
PHYL Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.18b USD (1.18b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.18b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.18b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.56% (E(1.18b)/V(1.18b) * Re(6.56%) + (debt-free company))
Discount Rate = 6.56% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)